Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Completed Phase 1 / 2 Trials for Nilotinib (DB04868)

IndicationStatusPhase
DBCOND0029916 (Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00702403Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous LeukemiaTreatment